Skip to main content
. 2023 Jul 25;13:11995. doi: 10.1038/s41598-023-38300-9

Figure 1.

Figure 1

CF and nonCF MDM phagocytosis is augmented by CFTR modulators. (A) MDM from CF subjects (n = 7) were treated for 48 h with DMSO or CFTR modulators as indicated. Phagocytosis was measured by gentamicin protection assay. Each line connecting dots represents a single subject, bars represent means of separate experiments. p < 0.001 for DMSO versus TI and p < 0.0001 for DMSO versus ETI. There were no significant differences between bacterial strains, and no interactions between strain and modulators. (B) Identical experiments were carried out with nonCF donors (n = 9). p < 0.01 for DMSO versus TI, p < 0.0001 for DMSO versus ETI. All statistics by mixed effects linear model.